Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,300 | 24 | 91.7% |
| Food and Beverage | $2,112 | 29 | 3.8% |
| Travel and Lodging | $1,526 | 8 | 2.7% |
| Consulting Fee | $1,000 | 4 | 1.8% |
| Education | $6.35 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $39,384 | 38 | $0 (2018) |
| Amgen Inc. | $10,724 | 16 | $0 (2017) |
| PFIZER INC. | $5,274 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $194.27 | 3 | $0 (2018) |
| Impulse Dynamics (USA) Inc. | $152.50 | 1 | $0 (2023) |
| Lantheus Medical Imaging, Inc. | $98.48 | 1 | $0 (2017) |
| Medtronic Vascular, Inc. | $94.28 | 1 | $0 (2018) |
| Novo Nordisk Inc | $11.87 | 1 | $0 (2021) |
| Braemar Manufacturing, LLC | $10.26 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $152.50 | 1 | Impulse Dynamics (USA) Inc. ($152.50) |
| 2021 | $11.87 | 1 | Novo Nordisk Inc ($11.87) |
| 2019 | $3,400 | 2 | PFIZER INC. ($3,400) |
| 2018 | $17,532 | 19 | E.R. Squibb & Sons, L.L.C. ($17,265) |
| 2017 | $34,848 | 43 | E.R. Squibb & Sons, L.L.C. ($22,119) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $152.50 | General |
| Category: Cardiovascular Device | ||||||
| 03/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Diabetes | ||||||
| 04/01/2019 | PFIZER INC. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/27/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| Category: Cardiovascular | ||||||
| 11/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| Category: Cardiovascular | ||||||
| 11/01/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $63.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| Category: Cardiovascular | ||||||
| 10/24/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $97.76 | General |
| Category: Cardiovascular | ||||||
| 10/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular | ||||||
| 10/18/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $81.66 | General |
| Category: Cardiovascular | ||||||
| 10/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $70.38 | General |
| Category: Cardiovascular | ||||||
| 09/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $108.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| Category: Cardiovascular | ||||||
| 04/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $106.24 | General |
| Category: Cardiovascular | ||||||
| 04/09/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Cardiovascular | ||||||
| 03/23/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular | ||||||
| 03/14/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Cardiovascular | ||||||
| 03/08/2018 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $94.28 | General |
| Category: Transcatheter Valve Systems | ||||||
| 03/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Cardiovascular | ||||||
| 03/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Cardiovascular | ||||||
| 02/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| Category: Cardiovascular | ||||||
| 01/30/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular | ||||||
| 12/26/2017 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Cardiology | ||||||
| 12/20/2017 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,537 | 3,787 | $977,195 | $178,214 |
| 2022 | 20 | 2,733 | 4,062 | $1.0M | $190,062 |
| 2021 | 22 | 2,921 | 4,224 | $1.1M | $206,414 |
| 2020 | 20 | 2,705 | 3,776 | $898,215 | $165,230 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 502 | 1,029 | $275,772 | $95,446 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 97 | 220 | $58,080 | $21,641 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 290 | 295 | $314,175 | $14,002 | 4.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 71 | $34,648 | $9,868 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 97 | $17,848 | $6,396 | 35.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 400 | 498 | $44,820 | $5,330 | 11.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 576 | 743 | $30,463 | $4,810 | 15.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 46 | $15,318 | $4,433 | 28.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 62 | 62 | $76,508 | $3,715 | 4.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 49 | $52,185 | $2,225 | 4.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $8,715 | $2,187 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,896 | $1,712 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 28 | $5,096 | $1,537 | 30.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 56 | 302 | $3,020 | $1,262 | 41.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 39 | 67 | $3,417 | $1,123 | 32.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 72 | 72 | $5,040 | $799.14 | 15.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 24 | $12,216 | $492.48 | 4.0% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 24 | 24 | $3,096 | $467.20 | 15.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 48 | 50 | $2,050 | $330.75 | 16.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 17 | 17 | $2,346 | $212.66 | 9.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 25 | 26 | $3,510 | $153.66 | 4.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 27 | 28 | $3,976 | $70.56 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 515 | 1,017 | $272,556 | $96,033 | 35.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 120 | 248 | $65,472 | $20,825 | 31.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 303 | 306 | $325,890 | $16,189 | 5.0% |
About Dr. David Brill, M.D
Dr. David Brill, M.D is a Cardiovascular Disease healthcare provider based in Waterford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437146404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brill, M.D has received a total of $55,944 in payments from pharmaceutical and medical device companies, with $152.50 received in 2023. These payments were reported across 66 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($51,300).
As a Medicare-enrolled provider, Brill has provided services to 10,896 Medicare beneficiaries, totaling 15,849 services with total Medicare billing of $739,920. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Waterford, CT
- Active Since 10/04/2005
- Last Updated 11/29/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1437146404
Products in Payments
- ELIQUIS (Drug) $44,658
- Repatha (Biological) $10,682
- ENTRESTO (Drug) $194.27
- OPTIMIZER (Device) $152.50
- Definity (Drug) $98.48
- CoreValve Evolut (Device) $94.28
- Corlanor (Drug) $42.05
- Ozempic (Drug) $11.87
- Cardiac Monitoring Suite (Device) $10.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Waterford
Dr. John Dickey, Do, DO
Cardiovascular Disease — Payments: $7,638
Dr. Leonard Salvia, D.o, D.O
Cardiovascular Disease — Payments: $6,170
Dr. Creagh Milford, D.o, D.O
Cardiovascular Disease — Payments: $6,003
Amy O'neil, Do, DO
Cardiovascular Disease — Payments: $4,161
Navneet Kumar, M.d, M.D
Cardiovascular Disease — Payments: $4,061
Robert Kupis, Pa-C, PA-C
Cardiovascular Disease — Payments: $3,946